Publication:
The incorporation of the Halal Management System (HMS) by the pharmaceutical industry

Simple item page
dc.contributor.authorKa-Liong Tan
dc.contributor.authorAinoon Othman
dc.contributor.authorIrwan Mohd Subr
dc.contributor.authorNoor Fadzilah Zulkifl i
dc.contributor.authorMohd Mahyeddin Mohd Salleh
dc.contributor.authorNazariyah Yahaya
dc.contributor.authorKhairun Nain Nor Aripin
dc.contributor.authorShahirah Nadiah Shaharuddin
dc.contributor.authorSeri Azalina Mohd Ghazalli
dc.contributor.authorMuhammad Syazan Sulaiman
dc.date.accessioned2024-06-16T06:42:08Z
dc.date.available2024-06-16T06:42:08Z
dc.date.issued2023
dc.date.submitted2024-1-23
dc.descriptionGenerics and Biosimilars Initiative Journal, Volume 12 Issue 3 Page (87–94)
dc.description.abstractIn recent years there has been a rapid growth of the halal pharmaceutical industry, especially in the supply chain of solid oral dosage forms of medication. This article outlines aspects of the Halal Management System (HMS) in the development and production of halal pharmaceuticals. It explains the needs and requirements of HMS and identifies the challenges faced in implementation. The article outlines aspects of executions and hurdles encountered when standardizing halal certifi cation. The article also highlights the need for systematic traceability systems and effective product recall mechanisms to ensure adherence to halal requirements. It also highlights the grey areas for halal in terms of pharmaceutical manufacture that are brought about by use of non-halal raw materials, e.g. alcohol, gelatine, glycerin, lecithin, glutamic acid and stearates.
dc.identifier.citationTan Ka Liong,Ainoon Othman ; Irwan Mohd Subri ; Noor Fadzilah Zulkifl i ; Mohd Mahyeddin Mohd Salleh ; Nazariyah Yahaya ; Khairun Nain Nor Aripin ; Shahirah Nadiah Shaharuddin ; Seri Azalina Mohd Ghazalli ; Muhammad Syazan Sulaiman (2023). The incorporation of the Halal Management System (HMS) by the pharmaceutical industry. Generics and Biosimilars Initiative Journal, 12(3), 87–94. https://doi.org/10.5639/gabij.2023.1203.014
dc.identifier.doi10.5639/gabij.2023.1203.014
dc.identifier.epage9
dc.identifier.issn2033-6772
dc.identifier.issue3
dc.identifier.other873-32
dc.identifier.spage1
dc.identifier.urihttps://oarep.usim.edu.my/handle/123456789/20180
dc.identifier.urihttps://gabi-journal.net/the-incorporation-of-the-halal-management-system-hms-by-the-pharmaceutical-industry.html
dc.identifier.volume12
dc.language.isoen_US
dc.publisherGABI
dc.relation.ispartofGenerics and Biosimilars Initiative Journal
dc.relation.issn2033-6403
dc.relation.journalGenerics and Biosimilars Initiative Journal
dc.subject: Halal assurance
dc.subjecthalal pharmaceuticals
dc.subjecthalal management
dc.subjectoral dosage
dc.subjectsupply chain
dc.titleThe incorporation of the Halal Management System (HMS) by the pharmaceutical industry
dc.typetext::journal::journal article
dspace.entity.typePublication
oaire.citation.endPage9
oaire.citation.issue3
oaire.citation.startPage1
oaire.citation.volume12
oairecerif.author.affiliationUniversiti Sains Islam Malaysia
oairecerif.author.affiliationUniversiti Sains Islam Malaysia
oairecerif.author.affiliationUniversiti Sains Islam Malaysia
oairecerif.author.affiliationUniversiti Sains Islam Malaysia
oairecerif.author.affiliationUniversiti Sains Islam Malaysia
oairecerif.author.affiliationUniversiti Sains Islam Malaysia
oairecerif.author.affiliationUniversiti Sains Islam Malaysia
oairecerif.author.affiliation#PLACEHOLDER_PARENT_METADATA_VALUE#
oairecerif.author.affiliation#PLACEHOLDER_PARENT_METADATA_VALUE#
oairecerif.author.affiliation#PLACEHOLDER_PARENT_METADATA_VALUE#

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
The incorporation of the Halal Management System (HMS) by the pharmaceutical industry
Size:
175.13 KB
Format:
Adobe Portable Document Format
Download

Collections

Other Publications